Ryaltris Spray, Metered
Product Images NDC 59467-700

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Ryaltris (NDC 59467-700). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Specialty Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ctn.jpg (Ctn)

Ryaltris nasal spray packaging label showing strengths of 665 mcg olopatadine hydrochloride and 25 mcg mometasone furoate per spray. The label includes instructions to shake the bottle well before each use, priming details, and dosing instructions. The product is for intranasal use only, with 240 metered sprays per container. It is labeled as Rx only and distributed by Hikma Specialty USA Inc.*

FDA Label Image

Figurea.jpg (Figurea)

An exploded view diagram of the Ryaltris nasal spray, metered. The image shows a white bottle labeled with Ryaltris and its active ingredients, olopatadine hydrochloride and mometasone furoate, with 240 metered sprays. The spray pump assembly is separated, displaying the dust cap in purple, spray pump unit with tip, and finger rest. Each component is labeled accordingly.*

FDA Label Image

Figureb.jpg (Figureb)

Ryaltris nasal spray metered dose bottle with a white body and a removable purple cap. The label shows the product name Ryaltris, active ingredients olopatadine hydrochloride and mometasone furoate, strength 665 mcg/25 mcg per spray, and the package contains 240 metered sprays. The labeler is HIKMA SPECIALTY USA INC.*

FDA Label Image

Figurec.jpg (Figurec)

Ryaltris nasal spray bottle held in a hand, labeled with active ingredients olopatadine hydrochloride and mometasone furoate. The label indicates a strength of 665 mcg/25 per spray, and notes 240 metered sprays with a net fill weight of 29 g. The spray nozzle is dispensing a mist. Labeler is HIKMA Specialty USA Inc.*

FDA Label Image

Figured.jpg (Figured)

A photographic illustration showing a woman holding a tissue to her nose, suggesting nasal discomfort or symptoms. The image does not display any packaging or product information.*

FDA Label Image

Figuree.jpg (Figuree)

Ryaltris nasal spray bottle held in a hand. The label shows the product name Ryaltris with olopatadine hydrochloride and mometasone furoate and strength of 665 mcg/25 mcg per spray. The bottle size is indicated for 240 metered sprays. The label also notes use for intranasal administration and the product is from HIKMA SPECIALTY USA INC.*

FDA Label Image

Figuref.jpg (Figuref)

An instructional image showing a woman using a metered nasal spray bottle, demonstrating proper administration technique by inserting the nozzle into one nostril and using her finger to apply the spray. The product label on the bottle is partially visible but not fully legible.*

FDA Label Image

Figureg.jpg (Figureg)

Instructional image showing a woman demonstrating the use of Ryaltris nasal spray, a metered-dose nasal spray containing olopatadine hydrochloride and mometasone furoate. She is holding the spray bottle near her nose and indicating the proper nasal application technique.*

FDA Label Image

Figureh.jpg (Figureh)

Ryaltris nasal spray bottle label showing the active ingredients olopatadine hydrochloride and mometasone furoate with a strength of 665 mcg/25 mcg per spray. The label indicates it is for intranasal use, contains 240 metered sprays, and has a net fill weight of 29 grams. The label also includes the product NDC 59467-700.*

FDA Label Image

Figurei.jpg (Figurei)

Ryaltris nasal spray, metered dose, containing olopatadine hydrochloride and mometasone furoate with a strength of 665 mcg per 25 mg spray. The product is shown in a white plastic bottle with a magenta spray cap being held by two hands. The label includes the proprietary name, active ingredients, dosage form, strength, and states the bottle contains 240 metered sprays with a net fill weight of 29 g. Manufactured by Hikma Specialty USA Inc.*

FDA Label Image

Figurej.jpg (Figurej)

Ryaltris nasal spray, metered, containing olopatadine hydrochloride and mometasone furoate. The label shows the strength as 665 mcg/25 mcg per spray, with 240 metered sprays in a 29-gram bottle. The product is from Hikma Specialty USA Inc. The image depicts the bottle with a white cap and a pink nasal applicator being removed.*

FDA Label Image

Figurek.jpg (Figurek)

An instructional image showing a person rinsing a white nasal spray actuator under running water from a faucet, demonstrating cleaning or maintenance of the spray device.*

FDA Label Image

Figurel.jpg (Figurel)

Ryaltris nasal spray, metered dose spray bottle held in hands. The label shows the proprietary name Ryaltris with active ingredients olopatadine hydrochloride and mometasone furoate, strength 665 mcg/25 mcg per spray, and route indicated as nasal. The bottle is white with a maroon spray nozzle and includes quantity information of 29 g net weight. Labeler is HIKMA SPECIALTY USA INC.*

FDA Label Image

Lbl.jpg (Lbl)

Ryaltris nasal spray label showing the active ingredients olopatadine hydrochloride and mometasone furoate with strengths of 665 mcg and 25 mcg per spray. The label includes usage instructions to shake the bottle well before use, priming information, storage conditions, and notes 240 metered sprays with a net fill weight of 29 g. It is labeled for intranasal use only and is distributed by Hikma Specialty USA Inc.*

FDA Label Image

Structure-mometasone.jpg (Structure Mometasone)

Chemical structure diagram of the active ingredient mometasone furoate in Ryaltris nasal spray. The structure shows molecular bonds and functional groups, including chlorines and a furoate ester, with a water molecule indicated.*

FDA Label Image

Structure-olopatadine.jpg (Structure Olopatadine)

Chemical structure diagram of olopatadine hydrochloride, one of the active ingredients in Ryaltris nasal spray.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.